Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.0523492999319583e-54,140.4670879410216,17364.627079999413,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.4033298157877095e-52,0,0,71
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.571946079118619e-24,18.7502618410334,1018.465086086395,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",4.012235883425046e-22,0,0,43
3,Nonalcoholic fatty liver disease WP4396,4.6827800328373215e-17,10.373313343328336,390.03714833293446,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",4.870091234150814e-15,0,0,37
4,Oxidative phosphorylation WP623,8.223797615337522e-12,13.444444444444445,343.1558523335967,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",6.414562139963267e-10,0,0,22
5,Mitochondrial CIV Assembly WP4922,7.655967305907277e-11,29.124031007751938,678.3846166775502,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",4.777323598886141e-09,0,0,16
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.3458520315992334e-10,18.583697234352258,412.06007741058016,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",1.2198430564316013e-08,0,0,17
7,Mitochondrial complex III assembly WP4921,3.6994164074018494e-07,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.648882741584824e-05,0,0,8
8,Pyrimidine metabolism WP4022,9.304542456634557e-05,5.416184971098266,50.27531858233939,"['NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.003628771558087477,0,0,12
9,Proteasome Degradation WP183,0.0009011894557370044,7.542324246771879,52.88523181691385,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMB10', 'PSMB8', 'PSMB9']",0.031241234465549484,0,0,7
10,Cellular Proteostasis WP4918,0.0026851112576004935,21.48,127.16231131357387,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.0837754712371354,0,0,4
11,Microglia Pathogen Phagocytosis Pathway WP3937,0.008033612525536152,3.2330935251798563,15.596834284241151,"['C1QA', 'HCK', 'ITGAM', 'TYROBP', 'NCF4', 'ITGB2', 'CYBB', 'CYBA', 'C1QC']",0.22786246436066177,0,0,9
12,Macrophage markers WP4146,0.01440850922785464,7.156190476190476,30.341791972397726,"['CD74', 'CD163', 'CD14', 'CD68']",0.37462123992422064,0,0,4
13,mRNA Processing WP411,0.019411981925465765,4.475441106342394,17.641583665524234,"['LSM7', 'SNRPD1', 'SNRPE', 'SRSF9', 'LSM2']",0.46588756621117833,0,0,5
14,DNA Repair Pathways Full Network WP4946,0.02105261421682727,3.5826170009551097,13.83151885345453,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'APEX1', 'POLE3']",0.4691725454035791,0,0,6
15,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.02484128649689545,inf,inf,"['ELOB', 'ELOC']",0.4926428384309271,0,0,2
16,Base Excision Repair WP4752,0.025263735304150107,5.365714285714286,19.737164545695563,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.4926428384309271,0,0,4
17,DNA Mismatch Repair WP531,0.05384754529118662,5.359486447931526,15.658267355948201,"['POLE4', 'POLD4', 'POLE3']",0.9882608312264838,0,0,3
18,Dual hijack model of Vif in HIV infection WP3300,0.06670751986356907,10.709401709401709,28.99503676336183,"['ELOB', 'ELOC']",0.999438104657753,0,0,2
19,Iron metabolism in placenta WP2007,0.06670751986356907,10.709401709401709,28.99503676336183,"['HEPHL1', 'FTH1']",0.999438104657753,0,0,2
20,Peroxiredoxin 2 induced ovarian failure WP4873,0.06670751986356907,10.709401709401709,28.99503676336183,"['STAR', 'BAX']",0.999438104657753,0,0,2
21,Ferroptosis WP4313,0.07356655749669631,2.6824034334763946,6.999905414024626,"['MAP1LC3A', 'GPX4', 'FTH1', 'CYBB', 'FTL']",0.999438104657753,0,0,5
22,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.08069954875816343,3.063673469387755,7.711334428024315,"['ITGAM', 'TYROBP', 'ITGB2', 'CD14']",0.999438104657753,0,0,4
23,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.08342685483344102,4.018544935805991,9.981201717961078,"['ZAP70', 'HLA-DRA', 'HLA-DRB1']",0.999438104657753,0,0,3
24,Selenium Micronutrient Network WP15,0.11666324695587925,1.7260020554984583,3.7082528062096887,"['SELENOM', 'PRDX5', 'GPX4', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'F2', 'SELENOH']",0.999438104657753,0,0,9
25,Ciliary landscape WP4352,0.11666324695587925,1.7260020554984583,3.7082528062096887,"['PSMD7', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'MCM5', 'COX6C', 'DCAF11', 'LSM4']",0.999438104657753,0,0,9
26,Eukaryotic Transcription Initiation WP405,0.11832475126600141,3.2139800285306706,6.8596692637380645,"['POLR2I', 'POLR2J', 'POLR2K']",0.999438104657753,0,0,3
27,Nanomaterial induced apoptosis WP2507,0.11832475126600141,3.2139800285306706,6.8596692637380645,"['ENDOG', 'BAX', 'CYCS']",0.999438104657753,0,0,3
28,Nucleotide Excision Repair WP4753,0.11832475126600141,3.2139800285306706,6.8596692637380645,"['POLE4', 'POLD4', 'POLE3']",0.999438104657753,0,0,3
29,Modulators of TCR signaling and T cell activation WP5072,0.1412168311466122,2.0617365467150877,4.035764264739971,"['ZAP70', 'NDUFB10', 'RHOH', 'ELOB', 'RNF7']",0.999438104657753,0,0,5
30,Autosomal recessive Osteopetrosis pathways WP4788,0.15770583665823618,inf,inf,['TCIRG1'],0.999438104657753,0,0,1
31,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.15770583665823618,inf,inf,['MAP1LC3A'],0.999438104657753,0,0,1
32,Mitochondrial CII Assembly WP4920,0.15770583665823618,inf,inf,['SDHAF1'],0.999438104657753,0,0,1
33,Non-homologous end joining WP438,0.15770583665823618,inf,inf,['DCLRE1C'],0.999438104657753,0,0,1
34,Allograft Rejection WP2328,0.1653968126312428,1.787010506208214,3.2155605850245905,"['C1QA', 'HLA-DRA', 'HLA-DOA', 'HLA-DRB1', 'HLA-DPA1', 'C1QC']",0.999438104657753,0,0,6
35,TYROBP causal network in microglia WP3945,0.1679725901121691,1.5577164075191459,2.77889514348834,"['ITGAM', 'SLC7A7', 'TYROBP', 'ITGB2', 'CAPG', 'CYTL1', 'TCIRG1', 'SLC1A5', 'C1QC']",0.999438104657753,0,0,9
36,Glycosylation and related congenital defects WP4521,0.1790752248970472,3.567901234567901,6.136609268685854,"['DPM2', 'DPM3']",0.999438104657753,0,0,2
37,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.1790752248970472,3.567901234567901,6.136609268685854,"['MAP1LC3A', 'FTL']",0.999438104657753,0,0,2
38,Acute viral myocarditis WP4298,0.22740800918779738,1.6738197424892705,2.4789429023925154,"['ENDOG', 'ITGB2', 'CYCS', 'BAX', 'AIF1']",0.999438104657753,0,0,5
39,Cytosolic DNA-sensing pathway WP4655,0.23736017472383986,1.7847619047619048,2.566802748900459,"['RNF125', 'IKBKE', 'POLR2K', 'POLR2L']",0.999438104657753,0,0,4
40,Serotonin and anxiety WP3947,0.24168907342062132,2.675213675213675,3.7990794994930495,"['POMC', 'CRH']",0.999438104657753,0,0,2
41,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.24168907342062132,2.675213675213675,3.7990794994930495,"['HSD11B2', 'STAR']",0.999438104657753,0,0,2
42,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.24168907342062132,2.675213675213675,3.7990794994930495,"['H2AFZ', 'HIST1H3E']",0.999438104657753,0,0,2
43,"GPCRs, Class B Secretin-like WP334",0.24168907342062132,2.675213675213675,3.7990794994930495,"['ADGRE1', 'ADGRE2']",0.999438104657753,0,0,2
44,Histone Modifications WP2369,0.24168907342062132,2.675213675213675,3.7990794994930495,"['SET', 'HIST1H3E']",0.999438104657753,0,0,2
45,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.24168907342062132,2.675213675213675,3.7990794994930495,"['STAR', 'HRAS']",0.999438104657753,0,0,2
46,The alternative pathway of fetal androgen synthesis WP4524,0.2905703538493321,5.347083926031295,6.608512089293783,['STAR'],0.999438104657753,0,0,1
47,Metabolism of alpha-linolenic acid WP4586,0.2905703538493321,5.347083926031295,6.608512089293783,['ALOX5'],0.999438104657753,0,0,1
48,Nanoparticle triggered autophagic cell death WP2509,0.2905703538493321,5.347083926031295,6.608512089293783,['MAP1LC3A'],0.999438104657753,0,0,1
49,p38 MAPK Signaling Pathway WP400,0.30499395637083365,2.1396011396011394,2.540697867889547,"['DDIT3', 'HRAS']",0.999438104657753,0,0,2
50,Androgen receptor signaling pathway WP138,0.3127229065663611,1.5289795918367346,1.7773436165167937,"['SUMO1', 'BAG1', 'STUB1', 'PARK7']",0.999438104657753,0,0,4
51,Copper homeostasis WP3286,0.33742503580327077,1.6048502139800285,1.7435283853985506,"['SCO2', 'COX17', 'ATOX1']",0.999438104657753,0,0,3
52,Type II interferon signaling (IFNG) WP619,0.367217010634352,1.7825261158594492,1.7857387556403526,"['CYBB', 'PSMB9']",0.999438104657753,0,0,2
53,Cytokines and Inflammatory Response WP530,0.367217010634352,1.7825261158594492,1.7857387556403526,"['HLA-DRA', 'HLA-DRB1']",0.999438104657753,0,0,2
54,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.367217010634352,1.7825261158594492,1.7857387556403526,"['MAP1LC3A', 'DDIT3']",0.999438104657753,0,0,2
55,MET in type 1 papillary renal cell carcinoma WP4205,0.367217010634352,1.7825261158594492,1.7857387556403526,"['RPL11', 'HRAS']",0.999438104657753,0,0,2
56,Parkinson's disease pathway WP2371,0.367217010634352,1.7825261158594492,1.7857387556403526,"['CYCS', 'PARK7']",0.999438104657753,0,0,2
57,Regulation of Microtubule Cytoskeleton WP2038,0.367217010634352,1.7825261158594492,1.7857387556403526,"['PARD6A', 'F2RL2']",0.999438104657753,0,0,2
58,Sleep regulation WP3591,0.38381140124045715,1.4585656853845157,1.3967283194870366,"['STAR', 'CRH', 'HCRTR1']",0.999438104657753,0,0,3
59,Oxidative Damage WP3941,0.38381140124045715,1.4585656853845157,1.3967283194870366,"['C1QA', 'CYCS', 'C1QC']",0.999438104657753,0,0,3
60,VEGFA-VEGFR2 Signaling Pathway WP3888,0.38395496027026094,1.1041779706999457,1.0569523056544028,"['SET', 'SDF2L1', 'SSR4', 'SARS', 'RPL13A', 'CYBB', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'CLIC1', 'HRAS']",0.999438104657753,0,0,20
61,TNF-alpha signaling pathway WP231,0.3920118747515746,1.2735881190816813,1.192668337871183,"['BAX', 'CYBA', 'TXN', 'HRAS', 'NOX1']",0.999438104657753,0,0,5
62,Serotonin and anxiety-related events WP3944,0.4025017265259208,2.6728307254623043,2.4324253517023395,['CRH'],0.999438104657753,0,0,1
63,"COVID-19, thrombosis and anticoagulation WP4927",0.4025017265259208,2.6728307254623043,2.4324253517023395,['F2'],0.999438104657753,0,0,1
64,Homologous recombination WP186,0.4025017265259208,2.6728307254623043,2.4324253517023395,['POLD4'],0.999438104657753,0,0,1
65,Immune response to tuberculosis WP4197,0.4025017265259208,2.6728307254623043,2.4324253517023395,['PSMB8'],0.999438104657753,0,0,1
66,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4025017265259208,2.6728307254623043,2.4324253517023395,['HRAS'],0.999438104657753,0,0,1
67,MTHFR deficiency WP4288,0.4025017265259208,2.6728307254623043,2.4324253517023395,['CYCS'],0.999438104657753,0,0,1
68,Nanoparticle triggered regulated necrosis WP2513,0.4025017265259208,2.6728307254623043,2.4324253517023395,['FTL'],0.999438104657753,0,0,1
69,Nanoparticle-mediated activation of receptor signaling WP2643,0.4025017265259208,2.6728307254623043,2.4324253517023395,['HRAS'],0.999438104657753,0,0,1
70,Purine metabolism and related disorders WP4224,0.4025017265259208,2.6728307254623043,2.4324253517023395,['APRT'],0.999438104657753,0,0,1
71,Purine metabolism WP4792,0.4025017265259208,2.6728307254623043,2.4324253517023395,['APRT'],0.999438104657753,0,0,1
72,RalA downstream regulated genes WP2290,0.4025017265259208,2.6728307254623043,2.4324253517023395,['HRAS'],0.999438104657753,0,0,1
73,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4025017265259208,2.6728307254623043,2.4324253517023395,['BAX'],0.999438104657753,0,0,1
74,SARS coronavirus and innate immunity WP4912,0.4025017265259208,2.6728307254623043,2.4324253517023395,['IKBKE'],0.999438104657753,0,0,1
75,IL-18 signaling pathway WP4754,0.4182709835521466,1.101619778346121,0.9602001880924341,"['NRN1', 'IMP3', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'NOX1', 'ITM2C']",0.999438104657753,0,0,14
76,CAMKK2  Pathway WP4874,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['FIS1', 'MAP1LC3A']",0.999438104657753,0,0,2
77,Type 2 papillary renal cell carcinoma WP4241,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['ELOB', 'ELOC']",0.999438104657753,0,0,2
78,Complement Activation WP545,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['C1QA', 'C1QC']",0.999438104657753,0,0,2
79,IL1 and megakaryocytes in obesity WP2865,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['TLR1', 'F2']",0.999438104657753,0,0,2
80,Oxidative Stress WP408,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['CYBB', 'NOX1']",0.999438104657753,0,0,2
81,SARS-CoV-2 mitochondrial interactions WP5038,0.4271260500993639,1.5274725274725274,1.2993843878332323,"['IKBKE', 'NOX1']",0.999438104657753,0,0,2
82,Vitamin D Receptor Pathway WP2877,0.43334771270659267,1.1143131604226706,0.9318052029157013,"['LRRC25', 'COLEC11', 'ITGAM', 'ALOX5', 'S100A6', 'DACT2', 'TNFRSF11B', 'CD14', 'HLA-DRB1', 'NOX1']",0.999438104657753,0,0,10
83,Cancer immunotherapy by PD-1 blockade WP4585,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['ZAP70', 'HLA-DRB1']",0.999438104657753,0,0,2
84,TP53 network WP1742,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['SUMO1', 'BAX']",0.999438104657753,0,0,2
85,Eicosanoid Synthesis WP167,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['ALOX5', 'ALOX5AP']",0.999438104657753,0,0,2
86,IL-6 signaling pathway WP364,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['HCK', 'VIP']",0.999438104657753,0,0,2
87,Notch Signaling WP268,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['DTX3L', 'DLL3']",0.999438104657753,0,0,2
88,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['RNF125', 'IKBKE']",0.999438104657753,0,0,2
89,Nuclear receptors WP170,0.4839034785814766,1.3361823361823362,0.9698944272709319,"['NR0B1', 'NR2F2']",0.999438104657753,0,0,2
90,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.49679405626685297,1.7814129919393078,1.2462403886922262,['HRAS'],0.999438104657753,0,0,1
91,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.49679405626685297,1.7814129919393078,1.2462403886922262,['DLL3'],0.999438104657753,0,0,1
92,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.49679405626685297,1.7814129919393078,1.2462403886922262,['COX8A'],0.999438104657753,0,0,1
93,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.49679405626685297,1.7814129919393078,1.2462403886922262,['IDH3B'],0.999438104657753,0,0,1
94,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.49679405626685297,1.7814129919393078,1.2462403886922262,['SST'],0.999438104657753,0,0,1
95,Cancer immunotherapy by CTLA4 blockade WP4582,0.49679405626685297,1.7814129919393078,1.2462403886922262,['HLA-DRB1'],0.999438104657753,0,0,1
96,Type II diabetes mellitus WP1584,0.49679405626685297,1.7814129919393078,1.2462403886922262,['SURF1'],0.999438104657753,0,0,1
97,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.49679405626685297,1.7814129919393078,1.2462403886922262,['VIP'],0.999438104657753,0,0,1
98,Fatty acid beta-oxidation WP143,0.49679405626685297,1.7814129919393078,1.2462403886922262,['CPT1B'],0.999438104657753,0,0,1
99,Fatty acid transporters WP5061,0.49679405626685297,1.7814129919393078,1.2462403886922262,['FABP6'],0.999438104657753,0,0,1
100,Gastric acid production WP2596,0.49679405626685297,1.7814129919393078,1.2462403886922262,['VIP'],0.999438104657753,0,0,1
101,Genes targeted by miRNAs in adipocytes WP1992,0.49679405626685297,1.7814129919393078,1.2462403886922262,['TMSB4X'],0.999438104657753,0,0,1
102,LTF danger signal response pathway WP4478,0.49679405626685297,1.7814129919393078,1.2462403886922262,['CD14'],0.999438104657753,0,0,1
103,Methionine De Novo and Salvage Pathway WP3580,0.49679405626685297,1.7814129919393078,1.2462403886922262,['TXN'],0.999438104657753,0,0,1
104,Nanomaterial-induced inflammasome activation WP3890,0.49679405626685297,1.7814129919393078,1.2462403886922262,['NOX1'],0.999438104657753,0,0,1
105,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.49679405626685297,1.7814129919393078,1.2462403886922262,['EIF1'],0.999438104657753,0,0,1
106,Osteoclast Signaling WP12,0.49679405626685297,1.7814129919393078,1.2462403886922262,['TNFRSF11B'],0.999438104657753,0,0,1
107,Overview of nanoparticle effects WP3287,0.49679405626685297,1.7814129919393078,1.2462403886922262,['BAX'],0.999438104657753,0,0,1
108,Pyrimidine metabolism and related diseases WP4225,0.49679405626685297,1.7814129919393078,1.2462403886922262,['NT5C'],0.999438104657753,0,0,1
109,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.49679405626685297,1.7814129919393078,1.2462403886922262,['ANAPC11'],0.999438104657753,0,0,1
110,Non-small cell lung cancer WP4255,0.5163881997706149,1.1450988383941307,0.7567917814909958,"['CYCS', 'BAX', 'HRAS']",0.999438104657753,0,0,3
111,Translation Factors WP107,0.5370464456236451,1.1874010762899652,0.738172455064985,"['EEF1B2', 'EIF1']",0.999438104657753,0,0,2
112,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5370464456236451,1.1874010762899652,0.738172455064985,"['DCLRE1C', 'BAX']",0.999438104657753,0,0,2
113,DNA Replication WP466,0.5370464456236451,1.1874010762899652,0.738172455064985,"['POLD4', 'MCM5']",0.999438104657753,0,0,2
114,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5571212337980562,1.0684736091298146,0.6250275798083151,"['PSMC5', 'PSMD7', 'STUB1']",0.999438104657753,0,0,3
115,Apoptosis Modulation by HSP70 WP384,0.5762237075915766,1.3357041251778095,0.7363193376839373,['CYCS'],0.999438104657753,0,0,1
116,Biomarkers for pyrimidine metabolism disorders WP4584,0.5762237075915766,1.3357041251778095,0.7363193376839373,['NT5C'],0.999438104657753,0,0,1
117,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5762237075915766,1.3357041251778095,0.7363193376839373,['MAP1LC3A'],0.999438104657753,0,0,1
118,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5762237075915766,1.3357041251778095,0.7363193376839373,['BAX'],0.999438104657753,0,0,1
119,Nucleotide metabolism WP404,0.5762237075915766,1.3357041251778095,0.7363193376839373,['NME2'],0.999438104657753,0,0,1
120,Osteoblast Signaling WP322,0.5762237075915766,1.3357041251778095,0.7363193376839373,['TNFRSF11B'],0.999438104657753,0,0,1
121,7q11.23 copy number variation syndrome WP4932,0.604568288310234,0.9709090909090909,0.48860092074427686,"['ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.999438104657753,0,0,4
122,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6315359168266129,0.970991970991971,0.4462683598165643,"['ARHGDIB', 'CYCS']",0.999438104657753,0,0,2
123,Notch Signaling Pathway Netpath WP61,0.6315359168266129,0.970991970991971,0.4462683598165643,"['PSENEN', 'DLL3']",0.999438104657753,0,0,2
124,Integrin-mediated Cell Adhesion WP185,0.6320578329060831,0.9422673491650583,0.43228812009382356,"['ITGAM', 'ITGB2', 'HRAS']",0.999438104657753,0,0,3
125,Complement and Coagulation Cascades WP558,0.6357039484079084,0.9284472049689441,0.4206073011668573,"['C1QA', 'SERPINA1', 'F2', 'C1QC']",0.999438104657753,0,0,4
126,Ebola Virus Pathway on Host WP4217,0.6404356304049664,0.9202802032460164,0.4100829891723201,"['HLA-DRA', 'HLA-DOA', 'IKBKE', 'HLA-DRB1', 'HLA-DPA1']",0.999438104657753,0,0,5
127,Selective expression of chemokine receptors during T-cell polarization WP4494,0.6431305755914366,1.0682788051209104,0.47154627977098995,['CCR1'],0.999438104657753,0,0,1
128,Small Ligand GPCRs WP247,0.6431305755914366,1.0682788051209104,0.47154627977098995,['PTAFR'],0.999438104657753,0,0,1
129,BDNF-TrkB Signaling WP3676,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
130,TLR4 Signaling and Tolerance WP3851,0.6431305755914366,1.0682788051209104,0.47154627977098995,['IKBKE'],0.999438104657753,0,0,1
131,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HIST1H3E'],0.999438104657753,0,0,1
132,Energy Metabolism WP1541,0.6431305755914366,1.0682788051209104,0.47154627977098995,['UCP3'],0.999438104657753,0,0,1
133,ERK Pathway in Huntington's Disease WP3853,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
134,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
135,Farnesoid X receptor pathway WP2879,0.6431305755914366,1.0682788051209104,0.47154627977098995,['SLCO2B1'],0.999438104657753,0,0,1
136,Galanin receptor pathway WP4970,0.6431305755914366,1.0682788051209104,0.47154627977098995,['POMC'],0.999438104657753,0,0,1
137,Glutathione metabolism WP100,0.6431305755914366,1.0682788051209104,0.47154627977098995,['GPX4'],0.999438104657753,0,0,1
138,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6431305755914366,1.0682788051209104,0.47154627977098995,['IKBKE'],0.999438104657753,0,0,1
139,Interleukin-11 Signaling Pathway WP2332,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
140,MAPK Cascade WP422,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
141,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6431305755914366,1.0682788051209104,0.47154627977098995,['BAX'],0.999438104657753,0,0,1
142,Monoamine Transport WP727,0.6431305755914366,1.0682788051209104,0.47154627977098995,['TNFRSF11B'],0.999438104657753,0,0,1
143,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6431305755914366,1.0682788051209104,0.47154627977098995,['SCO2'],0.999438104657753,0,0,1
144,NOTCH1 regulation of endothelial cell calcification WP3413,0.6431305755914366,1.0682788051209104,0.47154627977098995,['DLL3'],0.999438104657753,0,0,1
145,PDGFR-beta pathway WP3972,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
146,Photodynamic therapy-induced unfolded protein response WP3613,0.6431305755914366,1.0682788051209104,0.47154627977098995,['DDIT3'],0.999438104657753,0,0,1
147,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
148,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6431305755914366,1.0682788051209104,0.47154627977098995,['HRAS'],0.999438104657753,0,0,1
149,NRF2 pathway WP2884,0.6455649166948748,0.914858780188293,0.4003691957346402,"['SERPINA1', 'FTH1', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL']",0.999438104657753,0,0,6
150,Regulation of Actin Cytoskeleton WP51,0.666794238182868,0.8893657606103959,0.36043661394693177,"['FGF17', 'TMSB4X', 'BRK1', 'CD14', 'F2']",0.999438104657753,0,0,5
151,Synaptic Vesicle Pathway WP2267,0.6728232971598892,0.8898385565052231,0.352618588315853,"['SLC32A1', 'PARK7']",0.999438104657753,0,0,2
152,Toll-like Receptor Signaling related to MyD88 WP3858,0.6728232971598892,0.8898385565052231,0.352618588315853,"['TLR1', 'IKBKE']",0.999438104657753,0,0,2
153,Pathways affected in adenoid cystic carcinoma WP3651,0.6728232971598892,0.8898385565052231,0.352618588315853,"['UHRF1', 'HRAS']",0.999438104657753,0,0,2
154,PPAR signaling pathway WP3942,0.6728232971598892,0.8898385565052231,0.352618588315853,"['FABP6', 'CPT1B']",0.999438104657753,0,0,2
155,Senescence and Autophagy in Cancer WP615,0.6930331708237477,0.8537142857142858,0.31303774776827503,"['GABARAPL2', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.999438104657753,0,0,4
156,Alzheimer's disease WP2059,0.697718991205373,0.8426308281402508,0.30329557014118247,"['PSENEN', 'ATP5MD', 'CYCS']",0.999438104657753,0,0,3
157,Male infertility WP4673,0.697718991205373,0.8426308281402508,0.30329557014118247,"['EPSTI1', 'HLA-DRA', 'PEX10']",0.999438104657753,0,0,3
158,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6994866183278605,0.889995258416311,0.31809197302189407,['HRAS'],0.999438104657753,0,0,1
159,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6994866183278605,0.889995258416311,0.31809197302189407,['IKBKE'],0.999438104657753,0,0,1
160,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6994866183278605,0.889995258416311,0.31809197302189407,['HRAS'],0.999438104657753,0,0,1
161,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6994866183278605,0.889995258416311,0.31809197302189407,['HRAS'],0.999438104657753,0,0,1
162,Gastric Cancer Network 2 WP2363,0.6994866183278605,0.889995258416311,0.31809197302189407,['S100A6'],0.999438104657753,0,0,1
163,IL17 signaling pathway WP2112,0.6994866183278605,0.889995258416311,0.31809197302189407,['IL17RA'],0.999438104657753,0,0,1
164,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6994866183278605,0.889995258416311,0.31809197302189407,['SUPT4H1'],0.999438104657753,0,0,1
165,Interferon type I signaling pathways WP585,0.6994866183278605,0.889995258416311,0.31809197302189407,['ZAP70'],0.999438104657753,0,0,1
166,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6994866183278605,0.889995258416311,0.31809197302189407,['BAX'],0.999438104657753,0,0,1
167,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6994866183278605,0.889995258416311,0.31809197302189407,['HLA-DRA'],0.999438104657753,0,0,1
168,16p11.2 proximal deletion syndrome WP4949,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['SPN', 'SEZ6L2']",0.999438104657753,0,0,2
169,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['APEX1', 'HRAS']",0.999438104657753,0,0,2
170,Genotoxicity pathway WP4286,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['RPS27', 'TRIAP1']",0.999438104657753,0,0,2
171,IL-3 signaling pathway WP286,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['HCK', 'HRAS']",0.999438104657753,0,0,2
172,Leptin signaling pathway WP2034,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['BAX', 'HRAS']",0.999438104657753,0,0,2
173,Prolactin Signaling Pathway WP2037,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['ZAP70', 'HRAS']",0.999438104657753,0,0,2
174,Prostaglandin Synthesis and Regulation WP98,0.7102724079903596,0.8211702827087443,0.28092786319627294,"['HSD11B2', 'S100A6']",0.999438104657753,0,0,2
175,Chemokine signaling pathway WP3929,0.719172780757087,0.8206593406593407,0.2705333413896874,"['CCR1', 'HCK', 'GNG10', 'HRAS']",0.999438104657753,0,0,4
176,Corticotropin-releasing hormone signaling pathway WP2355,0.7270446934026915,0.8002853067047075,0.25510480794026363,"['POMC', 'STAR', 'CRH']",0.999438104657753,0,0,3
177,Ectoderm Differentiation WP2858,0.7436315811583772,0.79005291005291,0.2340212196566573,"['TNFRSF11B', 'NR2F2', 'ARHGAP15', 'LY6E']",0.999438104657753,0,0,4
178,G Protein Signaling Pathways WP35,0.7440653448665555,0.7623117623117623,0.22535949636544,"['GNG10', 'HRAS']",0.999438104657753,0,0,2
179,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7440653448665555,0.7623117623117623,0.22535949636544,"['IFI27L2', 'HRAS']",0.999438104657753,0,0,2
180,7-oxo-C and 7beta-HC pathways WP5064,0.7469536436983463,0.7626498679130258,0.2225047404939708,['HSD11B2'],0.999438104657753,0,0,1
181,Alpha 6 Beta 4 signaling pathway WP244,0.7469536436983463,0.7626498679130258,0.2225047404939708,['HRAS'],0.999438104657753,0,0,1
182,ATM Signaling Network in Development and Disease  WP3878,0.7469536436983463,0.7626498679130258,0.2225047404939708,['DCLRE1C'],0.999438104657753,0,0,1
183,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7469536436983463,0.7626498679130258,0.2225047404939708,['ZAP70'],0.999438104657753,0,0,1
184,Transcriptional cascade regulating adipogenesis WP4211,0.7469536436983463,0.7626498679130258,0.2225047404939708,['DDIT3'],0.999438104657753,0,0,1
185,Cells and molecules involved in local acute inflammatory response  WP4493,0.7469536436983463,0.7626498679130258,0.2225047404939708,['ITGB2'],0.999438104657753,0,0,1
186,G13 Signaling Pathway WP524,0.7469536436983463,0.7626498679130258,0.2225047404939708,['ARHGDIB'],0.999438104657753,0,0,1
187,PDGF Pathway WP2526,0.7469536436983463,0.7626498679130258,0.2225047404939708,['HRAS'],0.999438104657753,0,0,1
188,T-cell receptor (TCR) signaling pathway WP69,0.7744222546077444,0.7113010446343779,0.18183558040387623,"['ZAP70', 'HRAS']",0.999438104657753,0,0,2
189,White fat cell differentiation WP4149,0.7744222546077444,0.7113010446343779,0.18183558040387623,"['DDIT3', 'NR2F2']",0.999438104657753,0,0,2
190,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7744222546077444,0.7113010446343779,0.18183558040387623,"['CSF3R', 'F2RL2']",0.999438104657753,0,0,2
191,Toll-like Receptor Signaling Pathway WP75,0.7789424623598096,0.7271430424069512,0.18165349091043548,"['TLR1', 'CD14', 'IKBKE']",0.999438104657753,0,0,3
192,Statin inhibition of cholesterol production WP430,0.7869320307657747,0.6671408250355618,0.15985588087723274,['APOC1'],0.999438104657753,0,0,1
193,Striated Muscle Contraction Pathway WP383,0.7869320307657747,0.6671408250355618,0.15985588087723274,['TPM2'],0.999438104657753,0,0,1
194,Canonical and non-canonical Notch signaling WP3845,0.7869320307657747,0.6671408250355618,0.15985588087723274,['DLL3'],0.999438104657753,0,0,1
195,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7869320307657747,0.6671408250355618,0.15985588087723274,['TNFRSF11B'],0.999438104657753,0,0,1
196,GABA receptor Signaling WP4159,0.7869320307657747,0.6671408250355618,0.15985588087723274,['SLC32A1'],0.999438104657753,0,0,1
197,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7869320307657747,0.6671408250355618,0.15985588087723274,['DDIT3'],0.999438104657753,0,0,1
198,Kallmann's Syndrome WP5074,0.7869320307657747,0.6671408250355618,0.15985588087723274,['GNRH1'],0.999438104657753,0,0,1
199,One-carbon metabolism and related pathways WP3940,0.7869320307657747,0.6671408250355618,0.15985588087723274,['GPX4'],0.999438104657753,0,0,1
200,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7869320307657747,0.6671408250355618,0.15985588087723274,['RAB13'],0.999438104657753,0,0,1
201,Thermogenesis WP4321,0.801584838458985,0.6666666666666666,0.14744297528565542,"['CPT1B', 'HRAS']",0.999438104657753,0,0,2
202,Melanoma WP4685,0.801584838458985,0.6666666666666666,0.14744297528565542,"['BAX', 'HRAS']",0.999438104657753,0,0,2
203,Complement system WP2806,0.8147194900368151,0.7197540888528013,0.14748582447320666,"['FCGR3A', 'RPS19', 'ITGB2', 'VSIG4', 'TXN']",0.999438104657753,0,0,5
204,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.8206018073814694,0.5928560139086455,0.11721788826263542,['TLR1'],0.999438104657753,0,0,1
205,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8206018073814694,0.5928560139086455,0.11721788826263542,['HCK'],0.999438104657753,0,0,1
206,Cardiac Hypertrophic Response WP2795,0.8206018073814694,0.5928560139086455,0.11721788826263542,['IKBKE'],0.999438104657753,0,0,1
207,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8206018073814694,0.5928560139086455,0.11721788826263542,['IKBKE'],0.999438104657753,0,0,1
208,Unfolded protein response WP4925,0.8206018073814694,0.5928560139086455,0.11721788826263542,['DDIT3'],0.999438104657753,0,0,1
209,IL-2 signaling pathway WP49,0.8206018073814694,0.5928560139086455,0.11721788826263542,['HRAS'],0.999438104657753,0,0,1
210,Ovarian infertility WP34,0.8206018073814694,0.5928560139086455,0.11721788826263542,['GJA4'],0.999438104657753,0,0,1
211,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8206018073814694,0.5928560139086455,0.11721788826263542,['BAX'],0.999438104657753,0,0,1
212,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8258041013303242,0.6272833919892743,0.12006059787839272,"['CYCS', 'BAX']",0.999438104657753,0,0,2
213,Exercise-induced Circadian Regulation WP410,0.8258041013303242,0.6272833919892743,0.12006059787839272,"['SUMO1', 'UCP3']",0.999438104657753,0,0,2
214,Prader-Willi and Angelman Syndrome WP3998,0.8258041013303242,0.6272833919892743,0.12006059787839272,"['POMC', 'GNRH1']",0.999438104657753,0,0,2
215,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8258041013303242,0.6272833919892743,0.12006059787839272,"['BAX', 'HRAS']",0.999438104657753,0,0,2
216,EGF/EGFR signaling pathway WP437,0.8413021921279149,0.6393723252496434,0.11048632468977863,"['NDUFA13', 'NEDD8', 'HRAS']",0.999438104657753,0,0,3
217,Hepatitis B infection WP4666,0.8420603048757929,0.6657142857142857,0.1144387131161698,"['CYCS', 'BAX', 'IKBKE', 'HRAS']",0.999438104657753,0,0,4
218,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8473314199101512,0.5922760367204811,0.09811844662626183,"['BAX', 'HRAS']",0.999438104657753,0,0,2
219,Endometrial cancer WP4155,0.8473314199101512,0.5922760367204811,0.09811844662626183,"['BAX', 'HRAS']",0.999438104657753,0,0,2
220,Amyotrophic lateral sclerosis (ALS) WP2447,0.8489572808747295,0.5334281650071123,0.087346947507625,['BAX'],0.999438104657753,0,0,1
221,Blood Clotting Cascade WP272,0.8489572808747295,0.5334281650071123,0.087346947507625,['F2'],0.999438104657753,0,0,1
222,Vitamin D-sensitive calcium signaling in depression WP4698,0.8489572808747295,0.5334281650071123,0.087346947507625,['GPX4'],0.999438104657753,0,0,1
223,Endothelin Pathways WP2197,0.8489572808747295,0.5334281650071123,0.087346947507625,['RIIAD1'],0.999438104657753,0,0,1
224,Inflammatory Response Pathway WP453,0.8489572808747295,0.5334281650071123,0.087346947507625,['ZAP70'],0.999438104657753,0,0,1
225,Neural Crest Cell Migration during Development WP4564,0.8489572808747295,0.5334281650071123,0.087346947507625,['F2RL2'],0.999438104657753,0,0,1
226,Neural Crest Cell Migration in Cancer WP4565,0.8489572808747295,0.5334281650071123,0.087346947507625,['F2RL2'],0.999438104657753,0,0,1
227,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8489572808747295,0.5334281650071123,0.087346947507625,['CYCS'],0.999438104657753,0,0,1
228,RANKL/RANK signaling pathway WP2018,0.8489572808747295,0.5334281650071123,0.087346947507625,['TNFRSF11B'],0.999438104657753,0,0,1
229,Ras signaling WP4223,0.8573885528771807,0.6453679653679654,0.09929894559306944,"['ZAP70', 'GNG10', 'RASAL3', 'HRAS']",0.999438104657753,0,0,4
230,Folate Metabolism WP176,0.8664121903667265,0.5609536662168241,0.08043767792706247,"['GPX4', 'F2']",0.999438104657753,0,0,2
231,Glycolysis and Gluconeogenesis WP534,0.8664121903667265,0.5609536662168241,0.08043767792706247,"['LDHC', 'SLC2A5']",0.999438104657753,0,0,2
232,AMP-activated protein kinase (AMPK) signaling WP1403,0.8728362330752883,0.48480537954222164,0.06593708607454225,['CPT1B'],0.999438104657753,0,0,1
233,Cardiac Progenitor Differentiation WP2406,0.8728362330752883,0.48480537954222164,0.06593708607454225,['MESP1'],0.999438104657753,0,0,1
234,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8728362330752883,0.48480537954222164,0.06593708607454225,['ALOX5'],0.999438104657753,0,0,1
235,Integrated Cancer Pathway WP1971,0.8728362330752883,0.48480537954222164,0.06593708607454225,['BAX'],0.999438104657753,0,0,1
236,Kit receptor signaling pathway WP304,0.8728362330752883,0.48480537954222164,0.06593708607454225,['HRAS'],0.999438104657753,0,0,1
237,Metabolic reprogramming in colon cancer WP4290,0.8728362330752883,0.48480537954222164,0.06593708607454225,['SLC1A5'],0.999438104657753,0,0,1
238,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8728362330752883,0.48480537954222164,0.06593708607454225,['BAX'],0.999438104657753,0,0,1
239,Pregnane X receptor pathway WP2876,0.8728362330752883,0.48480537954222164,0.06593708607454225,['PSMC5'],0.999438104657753,0,0,1
240,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8728362330752883,0.48480537954222164,0.06593708607454225,['STAR'],0.999438104657753,0,0,1
241,DNA damage response WP707,0.8832814656165537,0.5327635327635327,0.06612201117221875,"['CYCS', 'BAX']",0.999438104657753,0,0,2
242,miRNA regulation of DNA damage response WP1530,0.8832814656165537,0.5327635327635327,0.06612201117221875,"['CYCS', 'BAX']",0.999438104657753,0,0,2
243,Apoptosis Modulation and Signaling WP1772,0.8842671945765287,0.6081632653061224,0.07480165245003821,"['ENDOG', 'CYCS', 'BAX', 'TNFRSF11B']",0.999438104657753,0,0,4
244,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8929445308471405,0.4442863916548127,0.05030691046377794,['HRAS'],0.999438104657753,0,0,1
245,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8929445308471405,0.4442863916548127,0.05030691046377794,['ZAP70'],0.999438104657753,0,0,1
246,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8929445308471405,0.4442863916548127,0.05030691046377794,['ITGB2'],0.999438104657753,0,0,1
247,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8929445308471405,0.4442863916548127,0.05030691046377794,['IKBKE'],0.999438104657753,0,0,1
248,Regulation of toll-like receptor signaling pathway WP1449,0.8959726114154607,0.5911111111111111,0.06493085659606004,"['TLR1', 'CUEDC2', 'CD14', 'IKBKE']",0.999438104657753,0,0,4
249,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8981611137299657,0.5072581739248406,0.05448247647973524,"['POMC', 'HRAS']",0.999438104657753,0,0,2
250,Peptide GPCRs WP24,0.8981611137299657,0.5072581739248406,0.05448247647973524,"['CCR1', 'HCRTR1']",0.999438104657753,0,0,2
251,Circadian rhythm related genes WP3594,0.9048726361587167,0.604109767199896,0.060387463989988004,"['STAR', 'CRH', 'AVP', 'RPS27A', 'HCRTR1']",0.999438104657753,0,0,5
252,Aryl Hydrocarbon Receptor Pathway WP2873,0.9098768722440062,0.4100010942116205,0.03872296082330029,['BAX'],0.999438104657753,0,0,1
253,Bladder cancer WP2828,0.9098768722440062,0.4100010942116205,0.03872296082330029,['HRAS'],0.999438104657753,0,0,1
254,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9098768722440062,0.4100010942116205,0.03872296082330029,['NDUFA13'],0.999438104657753,0,0,1
255,Apoptosis WP254,0.9227637940079833,0.46290102811841943,0.037208905063649746,"['CYCS', 'BAX']",0.999438104657753,0,0,2
256,Proximal tubule transport WP4917,0.9227637940079833,0.46290102811841943,0.037208905063649746,"['SLC7A7', 'SLC7A9']",0.999438104657753,0,0,2
257,Aryl Hydrocarbon Receptor Netpath WP2586,0.9241342737764862,0.3806136964031701,0.030029621341523496,['HRAS'],0.999438104657753,0,0,1
258,p53 transcriptional gene network WP4963,0.9241342737764862,0.3806136964031701,0.030029621341523496,['BAX'],0.999438104657753,0,0,1
259,Hippo-Merlin Signaling Dysregulation WP4541,0.9308155720343868,0.4985734664764622,0.03574478491834227,"['ITGAM', 'ITGB2', 'HRAS']",0.999438104657753,0,0,3
260,Small cell lung cancer WP4658,0.9328534932982376,0.44349477682811017,0.03082604379085239,"['CYCS', 'BAX']",0.999438104657753,0,0,2
261,ESC Pluripotency Pathways WP3931,0.9328534932982376,0.44349477682811017,0.03082604379085239,"['FGF17', 'HRAS']",0.999438104657753,0,0,2
262,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9361388099275629,0.35514461830251304,0.023436530445362643,['RNF7'],0.999438104657753,0,0,1
263,MECP2 and Associated Rett Syndrome WP3584,0.9361388099275629,0.35514461830251304,0.023436530445362643,['SST'],0.999438104657753,0,0,1
264,Oncostatin M Signaling Pathway WP2374,0.9361388099275629,0.35514461830251304,0.023436530445362643,['HRAS'],0.999438104657753,0,0,1
265,Pancreatic adenocarcinoma pathway WP4263,0.9361388099275629,0.35514461830251304,0.023436530445362643,['BAX'],0.999438104657753,0,0,1
266,TGF-beta Signaling Pathway WP366,0.9416869529453038,0.4256410256410256,0.025573526421189062,"['PARD6A', 'SUMO1']",0.999438104657753,0,0,2
267,Ciliopathies WP4803,0.9416869529453038,0.4256410256410256,0.025573526421189062,"['DNAAF3', 'CCDC28B']",0.999438104657753,0,0,2
268,DNA damage response (only ATM dependent) WP710,0.9416869529453038,0.4256410256410256,0.025573526421189062,"['BAX', 'HRAS']",0.999438104657753,0,0,2
269,AGE/RAGE pathway WP2324,0.9462460368953312,0.3328591749644381,0.018391355641299737,['CYCS'],0.999438104657753,0,0,1
270,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9462460368953312,0.3328591749644381,0.018391355641299737,['HRAS'],0.999438104657753,0,0,1
271,TGF-beta Receptor Signaling WP560,0.9462460368953312,0.3328591749644381,0.018391355641299737,['HRAS'],0.999438104657753,0,0,1
272,ErbB signaling pathway WP673,0.9462460368953312,0.3328591749644381,0.018391355641299737,['HRAS'],0.999438104657753,0,0,1
273,Glioblastoma signaling pathways WP2261,0.9462460368953312,0.3328591749644381,0.018391355641299737,['HRAS'],0.999438104657753,0,0,1
274,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9462460368953312,0.3328591749644381,0.018391355641299737,['BAX'],0.999438104657753,0,0,1
275,Breast cancer pathway WP4262,0.9466306112389168,0.5058503401360545,0.02774403162014318,"['FGF17', 'BAX', 'HRAS', 'DLL3']",0.999438104657753,0,0,4
276,B Cell Receptor Signaling Pathway WP23,0.9494088159477623,0.4091606399298707,0.021241896671602287,"['PIK3AP1', 'HRAS']",0.999438104657753,0,0,2
277,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9547554627765018,0.31319554848966613,0.01450096366997943,['TMSB4X'],0.999438104657753,0,0,1
278,Head and Neck Squamous Cell Carcinoma WP4674,0.9547554627765018,0.31319554848966613,0.01450096366997943,['HRAS'],0.999438104657753,0,0,1
279,Pathogenic Escherichia coli infection WP2272,0.9547554627765018,0.31319554848966613,0.01450096366997943,['CD14'],0.999438104657753,0,0,1
280,Pre-implantation embryo WP3527,0.9547554627765018,0.31319554848966613,0.01450096366997943,['DDIT3'],0.999438104657753,0,0,1
281,Nuclear Receptors Meta-Pathway WP2882,0.9552565546309373,0.6083341614495346,0.027846697591070356,"['PSMC5', 'SERPINA1', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'BAX', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL']",0.999438104657753,0,0,10
282,Cell cycle WP179,0.956149419126188,0.39390102353065315,0.017662948090746495,"['MCM5', 'ANAPC11']",0.999438104657753,0,0,2
283,Vitamin B12 metabolism WP1533,0.9619193724386984,0.2957167694009799,0.01148109837450033,['F2'],0.999438104657753,0,0,1
284,22q11.2 copy number variation syndrome WP4657,0.9620257018543429,0.3797313797313797,0.014700963001178345,"['RANBP1', 'MRPL40']",0.999438104657753,0,0,2
285,Endoderm differentiation WP2853,0.9671421835170472,0.3665389527458493,0.01224597794433167,"['HHEX', 'NME1']",0.999438104657753,0,0,2
286,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9679502639938823,0.2800778617953133,0.009123416809959829,['TNFRSF11B'],0.999438104657753,0,0,1
287,G1 to S cell cycle control WP45,0.9679502639938823,0.2800778617953133,0.009123416809959829,['MCM5'],0.999438104657753,0,0,1
288,Lung fibrosis WP3624,0.9679502639938823,0.2800778617953133,0.009123416809959829,['SERPINA1'],0.999438104657753,0,0,1
289,Integrated breast cancer pathway WP1984,0.9715919669310575,0.35422602089268757,0.010208563591948496,"['BAX', 'FAU']",0.999438104657753,0,0,2
290,Pathways in clear cell renal cell carcinoma WP4018,0.9730271159028656,0.26600284495021337,0.00727340326083264,['LDHC'],0.999438104657753,0,0,1
291,MAPK Signaling Pathway WP382,0.9793969580524913,0.424,0.008826936154922947,"['FGF17', 'DDIT3', 'CD14', 'HRAS']",0.999438104657753,0,0,4
292,Insulin Signaling WP481,0.9808978720023793,0.241691452217768,0.0046614863254832405,['HRAS'],0.999438104657753,0,0,1
293,Retinoblastoma gene in cancer WP2446,0.9808978720023793,0.241691452217768,0.0046614863254832405,['H2AFZ'],0.999438104657753,0,0,1
294,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9817215934394818,0.3217646550979884,0.005935760090374339,"['HRAS', 'DLL3']",0.999438104657753,0,0,2
295,Adipogenesis WP236,0.9864223113797816,0.3032153032153032,0.004145167989536204,"['GDF10', 'DDIT3']",0.999438104657753,0,0,2
296,Glucocorticoid Receptor Pathway WP2880,0.9864740046705637,0.22143195827406353,0.0030155279302474304,['ALOX5AP'],0.999438104657753,0,0,1
297,Hematopoietic Stem Cell Differentiation WP2849,0.9864740046705637,0.22143195827406353,0.0030155279302474304,['RHOH'],0.999438104657753,0,0,1
298,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9919428412299736,0.1966703545650914,0.0015910224744232855,['HRAS'],0.999438104657753,0,0,1
299,Spinal Cord Injury WP2431,0.9926289535557227,0.3241142391335992,0.0023979095584694614,"['APEX1', 'TNFSF13', 'AIF1']",0.999438104657753,0,0,3
300,Gastrin signaling pathway WP4659,0.9932211377565978,0.18959561064824224,0.0012896185550987085,['HRAS'],0.999438104657753,0,0,1
301,"GPCRs, Other WP117",0.9942968037597327,0.18300878010496885,0.0010467226643130591,['ADGRE2'],0.999438104657753,0,0,1
302,Neural Crest Differentiation WP2064,0.9952019201970108,0.1768610715979137,0.0008506358808301358,['DLL3'],0.999438104657753,0,0,1
303,Osteoblast differentiation WP4787,0.9952019201970108,0.1768610715979137,0.0008506358808301358,['DLL3'],0.999438104657753,0,0,1
304,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9969720234936258,0.3563005065150988,0.0010805062635443157,"['FGF17', 'GNG10', 'CSF3R', 'ITGB2', 'HRAS']",0.999438104657753,0,0,5
305,Myometrial relaxation and contraction pathways WP289,0.9978161089696891,0.22507122507122507,0.0004920685374324068,"['CRH', 'IGFBP6']",0.999438104657753,0,0,2
306,Mesodermal commitment pathway WP2857,0.9979784705005806,0.15139199349725665,0.00030635313621533294,['RPL38'],0.999438104657753,0,0,1
307,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9981296351163516,0.22032288698955366,0.0004124700459907989,"['SST', 'AVP']",0.999438104657753,0,0,2
308,"GPCRs, Class A Rhodopsin-like WP455",0.9981808382129392,0.3376618612670115,0.0006148209540667134,"['CCR1', 'GPR65', 'PTAFR', 'F2RL2', 'HCRTR1']",0.999438104657753,0,0,5
309,Focal Adhesion WP306,0.9988272905915694,0.2071951287637562,0.00024312226064259737,"['HCK', 'HRAS']",0.999438104657753,0,0,2
310,Metapathway biotransformation Phase I and II WP702,0.9991482416162772,0.13229018492176386,0.0001127272891162718,['GPX4'],0.999438104657753,0,0,1
311,Calcium Regulation in the Cardiac Cell WP536,0.9993970062574034,0.1259229153965996,7.59536321182223e-05,['GJA4'],0.999438104657753,0,0,1
312,PI3K-Akt signaling pathway WP4172,0.999438104657753,0.301991350533603,0.00016973522444682057,"['FGF17', 'GNG10', 'CSF3R', 'PIK3AP1', 'HRAS']",0.999438104657753,0,0,5
